ArticleAmerican journal of respiratory and critical care medicine2022
Erratum: Anti-Granulocyte-Macrophage Colony-Stimulating Factor Monoclonal Antibody Gimsilumab for COVID-19 Pneumonia: A Randomized, Double-Blind, Placebo-controlled Trial.
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.